Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions.

Authors

Charles L Bennett
Martin W Schoen
Shamia Hoque
Bartlett J Witherspoon
David M Aboulafia
Catherine S Hwang
Paul Ray
Paul R Yarnold
Brian K Chen
Benjamin Schooley
Matthew A Taylor
Michael D Wyatt
William J Hrushesky
Y Tony Yang, George Washington University

Document Type

Journal Article

Publication Date

12-1-2020

Journal

The Lancet Oncology

Volume

21

Issue

12

Inclusive Pages

e575-e588

DOI

10.1016/S1470-2045(20)30485-X

APA Citation

Bennett, C., Schoen, M., Hoque, S., Witherspoon, B., Aboulafia, D., Hwang, C., Ray, P., Yarnold, P., Chen, B., Schooley, B., Taylor, M., Wyatt, M., Hrushesky, W., & Yang, Y. (2020). Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions.. The Lancet Oncology, 21 (12). http://dx.doi.org/10.1016/S1470-2045(20)30485-X

Peer Reviewed

1